Merck (MRK) Restructuring Costs (2009 - 2026)

Merck (MRK) has 18 years of Restructuring Costs data on file, last reported at $195.0 million in Q1 2026.

• Restructuring Costs for Q1 2026 came in at $195.0 million, up 182.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 296.48% YoY), and the FY2025 annual result was $889.0 million, up 187.7% from the prior year.
• Restructuring Costs slipped to $195.0 million in Q1 2026 per MRK's latest filing, from $213.0 million in the prior quarter.
• Over five years, Restructuring Costs peaked at $560.0 million in Q2 2025 and troughed at $47.0 million in Q3 2025.
• A 5-year average of $137.1 million and a median of $94.0 million in 2022 frame the typical range for Restructuring Costs.
• The sharpest annual moves came in 2022 and 2025: Restructuring Costs slumped 82.15% in 2022, then jumped 600.0% in 2025.
• A 5-year view of Restructuring Costs shows it stood at $49.0 million in 2022, then surged by 420.41% to $255.0 million in 2023, then slumped by 80.0% to $51.0 million in 2024, then jumped by 317.65% to $213.0 million in 2025, then slipped by 8.45% to $195.0 million in 2026.
• Business Quant data shows MRK's Restructuring Costs at $195.0 million in Q1 2026, $213.0 million in Q4 2025, and $47.0 million in Q3 2025.